O-(5-O-(4-coumaroyl)-alpha-arabinofuranosyl)-(1-3)-O-beta-xylopyranosyl-(1-4)-xylopyranose: from bamboo shoot cell-wall; structure and properties given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 6438923 |
| MeSH ID | M0182179 |
| Synonym |
|---|
| d-xylose, o-5-o-(3-(4-hydroxyphenyl)-1-oxo-2-propenyl)-alpha-l-arabinofuranosyl-(1-3)-o-beta-d-xylopyranosyl-(1-4)- |
| o-(5-o-(4-coumaroyl)-alpha-arabinofuranosyl)-(1-3)-o-beta-xylopyranosyl-(1-4)-xylopyranose |
| o-(5-o-(trans-4-coumaroyl)-alpha-l-arabinofuranosyl)-(1-3)-o-beta-d-xylopyranosyl-(1-4)-d-xylopyranose |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 6 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||